22157.jpg
Small Cell Lung Cancer Therapeutics Market Forecast to Reach $10.87 Billion by 2028 Amid Advances in Early Detection and Treatment
February 19, 2024 04:38 ET | Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Small Cell Lung Cancer Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Growth in Small Cell Lung...
22157.jpg
Analysis of AstraZeneca's IMFINZI (Durvalumab) for Treating Malignant Pleural Mesothelioma (MPM): Regulatory Landmarks, Market Expansion, Intellectual Property, Future Challenges - Forecast to 2032
January 30, 2024 07:19 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "IMFINZI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
Emergen logo.png
Lung Cancer Therapeutics Market Size Worth USD 57.69 Billion in 2032 | Emergen Research
January 04, 2024 07:45 ET | Emergen Research
Vancouver, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The global lung cancer therapeutics market size was USD 28.00 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.7% during the...
22157.jpg
Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032
December 14, 2023 10:08 ET | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Pemetrexed + Cisplatin Drug Insights and Market Forecasts 2019-2032: The Standard of Care Front Line Regimen for Malignant Pleural Mesothelioma
December 12, 2023 04:58 ET | Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Research Nester Logo.jpg
Cholangiocarcinoma Market revenue to hit USD 1.3 Billion by 2036, says Research Nester
December 07, 2023 06:30 ET | Research Nester
New York , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global cholangiocarcinoma market size is projected to grow at a CAGR of over 4% from 2024 to 2036. The market is expected to garner a revenue of USD...
Research Nester Logo.jpg
Germ Cell Tumor Market revenue to hit USD 122 Billion by 2035, says Research Nester
November 21, 2023 06:30 ET | Research Nester
New York, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global germ cell tumor market size is projected to grow at a CAGR of over 12% from 2024-2036. The market is expected to garner a revenue of USD 122...
Global Ovarian Cancer Drugs Market
Global Ovarian Cancer Drugs Market Report 2023: Major Players Include AstraZeneca, Roche, Tesaro, Clovis Oncology and Amgen
April 14, 2023 10:28 ET | Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
22157.jpg
Extensive Stage Small Cell Lung Cancer Global Market Report 2022: Next-Generation Sequencing is Helping in Identifying New Molecular Targets
December 14, 2022 08:03 ET | Research and Markets
Dublin, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The "Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast,...
Decibel-full color-CMYK.png
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy
June 28, 2022 07:00 ET | Decibel Therapeutics, Inc.
- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support continued development of DB-020 as a potential...